Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Nextech and RxPhoto Partner to Improve Aesthetic Patient Education and Image Quality
March 04, 2019 10:22 ET
|
Nextech Systems, Inc.
TAMPA, Fla., March 04, 2019 (GLOBE NEWSWIRE) -- Nextech Systems, a leading health care technology provider for specialty physician practices, today announced its new partnership with RxPhoto, a...
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day
January 29, 2019 08:30 ET
|
ProQR Therapeutics N.V.
LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative...
Nextech Named as Finalist in 2019 Stevie® Awards for Sales & Customer Service
January 17, 2019 15:59 ET
|
Nextech Systems, Inc.
TAMPA, Fla., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Nextech Systems -- Nextech’s IntelleChartPRO Support Team was named a Finalist today in the Customer Service Department of the Year – Healthcare,...
ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leber’s Congenital Amaurosis 10
January 07, 2019 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
ProQR to Host R&D Day in New York on January 29
January 03, 2019 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & Development Day for investors on Tuesday, January 29 at...
ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2
January 02, 2019 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.
December 31, 2018 07:00 ET
|
Harrow Health, Inc.
SAN DIEGO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ: IMMY) announced it has formally changed its name and that it will trade...
Medical Biomimetics Market will expand at 5.5% CAGR to surpass USD 34 bn by 2024: Global Market Insights, Inc.
December 18, 2018 02:27 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Dec. 18, 2018 (GLOBE NEWSWIRE) -- China medical biomimetics market is anticipated to witness 8.5% CAGR during the forecast period. Growing geriatric population base in the...
ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10
December 10, 2018 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative...
Interface Biologics Announces New V.P., Business Development
December 04, 2018 08:00 ET
|
Interface Biologics Inc
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical...